Literature DB >> 16341903

Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations.

Irena Manolova1, Maria Dantcheva.   

Abstract

OBJECTIVE: The aim of this study was to study the prevalence, subspecificities, and immunoglobulin (Ig)G subclass distribution of antineutrophil cytoplasmic antibodies (ANCA) in 90 Bulgarian patients with rheumatoid arthritis (RA) and to investigate the clinical associations of ANCA in these patients.
METHODS: The ANCA were detected by indirect immunofluorescence, while antigen specificities were determined by enzyme-linked immunosorbent assay (ELISA) directed against myeloperoxidase (MPO), proteinase 3 (PR3), bactericidal/permeability-increasing protein (BPI), lactoferrin (LF), leukocyte elastase (LE), and cathepsin G (CG). The IgG subclass reactivity of antibodies to BPI and LF was measured.
RESULTS: Antineutrophil cytoplasmic antibodies were found in 18 RA patients. Only a P-ANCA fluorescence pattern was seen. Six sera reacted to BPI, five to LF, one to MPO, one to PR3, and one to CG by ELISA testing. Immunoglobulin-G1 was the predominant subclass for LF-ANCA, whereas IgG1/3 contributed mainly to BPI-ANCA. Compared to P-ANCA-negative RA patients, the P-ANCA-positive patients exhibited significantly higher inflammatory activity, as estimated by disease activity score, C-reactive protein, erythrocyte sedimentation rate, and higher levels of IgM rheumatoid factor.
CONCLUSION: Twenty percent of Bulgarian patients with RA have P-ANCA in their sera. These antibodies are directed against variable antigen specificities, while ANCA positivity in RA reflects disease and inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16341903     DOI: 10.1007/s00296-004-0517-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  47 in total

1.  Pitfalls of formalin fixation for determination of antineutrophil cytoplasmic antibodies.

Authors:  S M Chowdhury; V Broomhead; G P Spickett; R Wilkinson
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

2.  Comparative effects of antilactoferrin antibodies and tumor necrosis factor on neutrophil adherence to matrix proteins.

Authors:  B Zweiman; C von Allmen
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3.

Authors:  J C Jennette; J R Hoidal; R J Falk
Journal:  Blood       Date:  1990-06-01       Impact factor: 22.113

4.  Anti-neutrophil cytoplasm antibodies 1988.

Authors:  N Rasmussen; A Wiik; M Høier-Madsen; N Borregaard; F van der Woude
Journal:  Lancet       Date:  1988-03-26       Impact factor: 79.321

5.  Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis.

Authors:  P M Ellerbroek; M Oudkerk Pool; B U Ridwan; K M Dolman; B M von Blomberg; A E von dem Borne; S G Meuwissen; R Goldschmeding
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

6.  Antineutrophil cytoplasmic autoantibodies antigen specificity.

Authors:  P Lesavre
Journal:  Am J Kidney Dis       Date:  1991-08       Impact factor: 8.860

7.  Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy.

Authors:  A Mustila; M Korpela; J Mustonen; H Helin; H Huhtala; E Soppi; A Pasternack; A Miettinen
Journal:  Arthritis Rheum       Date:  1997-04

8.  Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis.

Authors:  J A Savige; M C Gallicchio; A Stockman; T J Cunningham; M J Rowley; T Georgiou; D Davies
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

9.  Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA).

Authors:  J Brimnes; P Halberg; S Jacobsen; A Wiik; N H Heegaard
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

10.  Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis.

Authors:  I E Coremans; E C Hagen; M R Daha; F J van der Woude; E A van der Voort; C Kleijburg-van der Keur; F C Breedveld
Journal:  Arthritis Rheum       Date:  1992-12
View more
  1 in total

1.  Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).

Authors:  M V Talor; J H Stone; J Stebbing; J Barin; N R Rose; C L Burek
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.